Akero Therapeutics Share Price Today
(NASDAQ: AKRO)

Name: Akero Therapeutics Share Price Today (NASDAQ: AKRO) - Akero Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Akero Therapeutics share price is $56.39 & ₹4,911.29 as on 5 Feb 2025, 2.30 'hrs' IST

$56.39

▲

2.54

(4.72%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Akero Therapeutics share price in Dollar and Rupees. Guide to invest in Akero Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Akero Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Akero Therapeutics share price movements

Today's Low: $54.12
Today's High: $57.19
$56.39
4.03%
Downside
Day's Volatility :5.37%
Upside
1.4%
52 Weeks Low: $15.32
52 Weeks High: $58.40
$56.39
72.83%
Downside
52 Weeks Volatility :73.77%
Upside
3.44%

Akero Therapeutics (AKRO) Returns

Period	Akero Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	52.64%	0.5%	0.0%
6 Months	127.41%	-2.3%	0.0%
1 Year	203.21%	3.8%	0.0%
3 Years	186.28%	11.4%	-11.7%

Akero Therapeutics (AKRO) Key Statistics

in dollars & INR

Previous Close	$53.85
Open	$53.6
Today's High	$57.1889
Today's Low	$54.115
Market Capitalization	$4.1B
Today's Volume	$1.2M
52 Week High	$58.4
52 Week Low	$15.32
Revenue TTM	$0.0
EBITDA	$-269.3M
Earnings Per Share (EPS)	$-3.78
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-35.9%

How to invest in Akero Therapeutics Stock (AKRO) from India?

It is very easy for Indian residents to invest directly in Akero Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Akero Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Akero Therapeutics or AKRO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Akero Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Akero Therapeutics shares which would translate to 0.015 fractional shares of Akero Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Akero Therapeutics, in just a few clicks!

Returns in Akero Therapeutics (AKRO) for Indian investors in Rupees

The Akero Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Akero Therapeutics investment value today

Current value as on today

₹3,22,376

Returns

₹2,22,376

(+222.38%)

Returns from Akero Therapeutics Stock

₹2,17,511 (+217.51%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Akero Therapeutics (AKRO)

271.43%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Investment in Akero Therapeutics Shares from India has grown by 271.43% over the past 30 days, indicating increased transactional activity.

283%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Akero Therapeutics Stock from India on INDmoney has increased by 283% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Akero Therapeutics

Wellington Management Company LLP
10.36%
HHG PLC
9.28%
RTW INVESTMENTS, LLC
7.77%
BlackRock Inc
7.54%
General Atlantic Llc
6.87%
T. Rowe Price Associates, Inc.
5.00%

Analyst Recommendation on Akero Therapeutics

Buy

87%Buy

12%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Akero Therapeutics(by analysts ranked 0 to 5 stars)

Based on 16 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Akero Therapeutics Stock (AKRO)

What analysts predicted

Upside of 38.81%

Target:

$78.27

Current:

$56.39

Insights on Akero Therapeutics Stock (Ticker Symbol: AKRO)

Price Movement
In the last 1 month, AKRO stock has moved up by 90.7%

Akero Therapeutics Technicals Summary

Sell

Neutral

Buy

Akero Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Akero Therapeutics (AKRO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Akero Therapeutics Inc	94.83%	127.41%	203.21%	186.28%	106.4%
Biontech Se	-0.32%	51.19%	24.81%	-30.66%	288.02%
Regeneron Pharmaceuticals, Inc.	-6.9%	-37.55%	-28.89%	7.15%	74.63%
Vertex Pharmaceuticals Incorporated	16.87%	0.96%	13.03%	93.36%	95.94%
Alnylam Pharmaceuticals, Inc.	17.76%	5.53%	59.46%	84.7%	118.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Akero Therapeutics Inc	NA	NA	NA	-3.95	-0.36	-0.23	NA	10.61
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.64	16.64	1.08	44.92	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Akero Therapeutics Inc	Buy	$4.1B	106.4%	NA	0.0%
Biontech Se	Buy	$29.7B	288.02%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$74.0B	74.63%	16.64	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$118.9B	95.94%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.0B	118.8%	NA	-15.86%

About Akero Therapeutics

Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Organization	Akero Therapeutics
Employees	60
CEO	Dr. Andrew Cheng M.D., Ph.D.
Industry	Health Technology

Management People of Akero Therapeutics

Name	Title
Dr. Andrew Cheng M.D., Ph.D.	President, CEO & Director
Dr. Jonathan M. Young J.D., Ph.D.	Co-Founder, Executive VP, COO & Secretary
Dr. Timothy Rolph Ph.D.	Co-Founder & Chief Scientific Officer
Mr. William R. White J.D.	Executive VP, CFO, Treasurer & Head of Corporate Development
Ms. Catriona Yale	Executive VP & Chief Development Officer
Mr. Scott A. Gangloff	Chief Technical Officer
Mr. Thomas Ross	Senior VP & Head of Legal
Mr. John J. Schembri	Senior VP & Head of Finance
Mr. Patrick Lamy	Senior Vice President of Commercial Strategy

Important FAQs about investing in AKRO Stock from India :

What is Akero Therapeutics share price today?

Akero Therapeutics share price today stands at $56.39, Open: $53.60 ; Previous Close: $53.85 ; High: $57.19 ; Low: $54.12 ; 52 Week High: $58.40 ; 52 Week Low: $15.32.

The stock opens at $53.60, after a previous close of $53.85. The stock reached a daily high of $57.19 and a low of $54.12, with a 52-week high of $58.40 and a 52-week low of $15.32.

Can Indians buy Akero Therapeutics shares?

Yes, Indians can invest in the Akero Therapeutics (AKRO) from India.

With INDmoney, you can buy Akero Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Akero Therapeutics at zero transaction cost.

How can I buy Akero Therapeutics shares from India?

It is very easy to buy Akero Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Akero Therapeutics (AKRO) be purchased?

Yes, you can buy fractional shares of Akero Therapeutics with INDmoney app.

What are the documents required to start investing in Akero Therapeutics stocks?

To start investing in Akero Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.